| FWWMX | RWMGX | FWWMX / RWMGX | |
| Total Expense Ratio | 0.31 | 0.26 | 119% |
| Annual Report Gross Expense Ratio | 0.31 | 0.26 | 119% |
| Fund Existence | 6 years | 17 years | - |
| Gain YTD | 5.819 | 5.068 | 115% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 219B | 219B | 100% |
| Annual Yield % from dividends | 1.42 | 1.47 | 97% |
| Returns for 1 year | 9.02 | 7.08 | 127% |
| Returns for 3 years | 31.24 | 28.27 | 111% |
| Returns for 5 years | 32.63 | 29.11 | 112% |
| Returns for 10 years | N/A | 81.27 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GSPAX | 20.13 | 0.12 | +0.60% |
| Goldman Sachs US Eq Div and Premium A | |||
| GSINX | 24.19 | N/A | N/A |
| Goldman Sachs GQG Ptnrs Intl Opps Inv | |||
| HRSCX | 24.46 | -0.06 | -0.24% |
| Carillon Eagle Small Cap Growth A | |||
| PIEQX | 22.30 | -0.17 | -0.76% |
| T. Rowe Price International Eq Index | |||
| RYBOX | 71.28 | -1.65 | -2.26% |
| Rydex Biotechnology A | |||